The Investor’s Crucible: The Questions That Are Making or Breaking Life Sciences Deals in 2025
Over the last twelve months, a clear and urgent pattern has emerged from hundreds of discussions with leaders across the life sciences investment landscape. In my role at ProGen Search, I have the unique privilege of sitting at the intersection of talent and capital. My conversations with founding partners at top-tier VC funds, seasoned operating […]